Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | ALK | Q9UM73 | 1/20 | 0.32 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.31 |
| ▸ | GPR3 | P46089 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20174957 | 1.00 | CYP1A2 (0.32) | CYP1A2ALKPDK2GPR3ALDH1A1 | |
| SCHEMBL20179324 | 0.94 | PDK2 (0.34) | ALKPDK2 | |
| SCHEMBL20199274 | 0.94 | PDK2 (0.34) | ALKPDK2 | |
| SCHEMBL20174916 | 0.94 | PDK2 (0.34) | ALKPDK2 | |
| SCHEMBL20199212 | 0.93 | ALDH1A1 (0.33) | ALKPDK2GPR3ALDH1A1POLB | |
| SCHEMBL20199223 | 0.93 | PDK2 (0.33) | ALKPDK2 | |
| SCHEMBL20199237 | 0.92 | ALK (0.32) | ALKPDK2 | |
| SCHEMBL20199285 | 0.92 | PDK2 (0.34) | CYP1A2PDK2 | |
| SCHEMBL20174959 | 0.91 | — | — | |
| SCHEMBL20174962 | 0.91 | ALOX5 (0.30) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3360868-B1 | SPIRO-TYPE COMPOUND AND ORGANIC LIGHT EMITTING DIODE COMPRISING SAME | LG CHEMICAL LTD (KR) | 2023-09-20 | — | — | EP | disclosed |
| US-11075342-B2 | Spiro-type compound and organic light emitting diode comprising same | LG CHEM, LTD. | 2021-07-27 | — | — | US | disclosed |
| US-20180145261-A1 | SPIRO-TYPE COMPOUND AND ORGANIC LIGHT EMITTING DIODE COMPRISING SAME | LG CHEM, LTD. (KR) | 2018-05-24 | — | — | US | disclosed |
| US-20180145261-A1 | SPIRO-TYPE COMPOUND AND ORGANIC LIGHT EMITTING DIODE COMPRISING SAME | LG CHEM, LTD. (KR) | 2018-05-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11075342-B2 | Spiro-type compound and organic light emitting diode comprising same | CRY1, NR2E3, ALDH1A2 | CYP1A2 334/4885ALK 3042/4885PDK2 580/4885 |
| US-20180145261-A1 | SPIRO-TYPE COMPOUND AND ORGANIC LIGHT EMITTING DIODE COMPRISING SAME | CRY1, NR2E3, ALDH1A2 | CYP1A2 334/4885ALK 3042/4885PDK2 580/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.